Quantcast
 
New book by Larry Connors - Click here to read more


 

Par Pharmaceutical Warns

Thu. August 07, 2008; Posted: 05:07 PM
Stocks RSS
Aug 07, 2008 (EarningsWhispers Guidance Summaries via Comtex) -- PRX | Quote | Chart | News | PowerRating -- Par Pharmaceutical Companies (NYSE: PRX | Quote | Chart | News | PowerRating) said it now expects 2008 results to range from a loss of $0.06 per share to earnings of $0.38 per share. The company's previous guidance was earnings of $0.65 to $0.85 per share and the current consensus earnings estimate is $0.75 per share for the year ending December 31, 2008.

This earnings guidance summary was provided by EarningsWhispers, a leading provider of earnings expectations - including corporate guidance announcements and analysts' expectations that differ from published estimates. http://www.earningswhispers.com

For full details on Par Pharmaceutical Co Inc (PRX) click here. Par Pharmaceutical Co Inc (PRX) has Short Term PowerRatings of 3. Details on Par Pharmaceutical Co Inc (PRX) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [PRX]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.